Mistakes in terminology cause false conclusions: Vitamin D does not increase the risk of dementia.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36173739.
- Also identified by DOI 10.1111/acel.13722 and PMC identifier 9577943.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There has been a progressive trend in recent years, to trivialize the terminology surrounding the molecules based on a secosteroid structure. The generic use of the term, "vitamin D," results in gross misrepresentations that confuse the use of a drug commonly used for patients with kidney failure, with the nutritional use of vitamin D. This commentary is a critique of one particularly bad example of that terminological trivialization. Authors may simply want to add impact to their findings when they refer to "vitamin D supplementation" when what they are reporting on is calcitriol. However, the consequences of this practice are to mislead all readers who do not go through the primary publication very carefully to understand the details behind sloppy terminology. Contrary to all the words written in the publication commented upon here, it offers no clinical evidence that vitamin D supplementation increases risk of Alzheimer's disease or dementia.
Medical subject headings
- Alzheimer Disease
- Vitamin D Deficiency